U.S. Nucleic Acid Therapeutics Cdmo Market Size & Outlook

Name: U.S. Nucleic Acid Therapeutics Cdmo Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The nucleic acid therapeutics cdmo market in the United States is expected to reach a projected revenue of US$ 17,004.0 million by 2033. A compound annual growth rate of 14.2% is expected of the United States nucleic acid therapeutics cdmo market from 2026 to 2033.

HC Outsourcing
- Clinical & Non-Clinical Outsourcing Services
  - Nucleic Acid Therapeutics CDMO Market Outlook

U.S. nucleic acid therapeutics cdmo type outlook (Revenue, USD million, 2021-2033)
- Gene Therapy
- RNA-based Therapies
U.S. nucleic acid therapeutics cdmo service outlook (Revenue, USD million, 2021-2033)
- Process Development and Optimization
- Manufacturing Services
- Analytical and Quality Control Services
- Others
U.S. nucleic acid therapeutics cdmo end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical Companies
- Government & Academic Research Institutes
- Biotech Companies
U.S. nucleic acid therapeutics cdmo application outlook (Revenue, USD million, 2021-2033)
- Rare Diseases
- Genetic Disorders
- Infectious Diseases
- Others

U.S. Nucleic Acid Therapeutics Cdmo Market Size & Outlook

Data Tree

Sign up - it's easy, and free!